The joint offering features an “Opportunity Analysis” to understand how AI-enhanced clinical navigation and population health care management could impact an employer’s utilization and future claim trend.
September 30, 2020 – Hunt Valley, MD & Columbia, MD – ArmadaHealth, a leading provider of physician recommendation intelligence and Healthcare Strategies, an industry leader in managing employer self-funded healthcare risk, are pleased to announce their new partnership, combining ArmadaHealth’s AI-enabled patient/physician matching solution, QualityCare Navigator, with Healthcare Strategies’ risk management solutions featuring their HealthReach Population Risk Management program. This new partnership will provide self-funded employers with a combination of guaranteed highly qualified and perfectly matched physicians along with ‘one on one’ RN Care Managers to support their members and reduce overall healthcare costs.
“Our HealthReach Population Risk Management solution currently shows an impact after 12 months and saves, on average, $3,486/per HealthReach participant along with improved compliance with chronic conditions across the entire population. With the addition of the QualityCare Navigator (QCN) platform, we anticipate additional member compliance and savings for each client,” said David Lauritzen, COO and Senior Consultant, Healthcare Strategies. “HealthReach is a proactive clinical-based solution that identifies emerging risk and members that are likely to develop a condition or have a healthcare event in the near future. Steering members to high-quality physicians at any point during the journey, can make a game-changing difference and is a fundamental cost-mitigation component of the service. The QCN solution enables the RN Care Managers to feel confident they are navigating members to the best-matched, high-performing doctor(s) for their needs.”
“We are excited to be working with one of the early leaders in healthcare cost containment and already have experienced great synergy between our solutions based on marketplace demand,” said Susan Torroella, CEO, ArmadaHealth. “Healthcare Strategies has decades of experience in demonstrating savings with their clients’ healthcare dollars. Our partnership enables the contributing savings from our solutions to be realized, mitigating the Total Cost of Care.”
ArmadaHealth’s QCN enables member-facing support teams to leverage a Navigation-as-a-Service™ model, amplifying their value-based care initiatives. QCN easily plugs into existing platforms and processes so groups can benefit from optimal care relatively quickly, while member-facing teams spend more time helping members. QCN is powered by ArmadaHealth’s enhanced intelligence data science platform, S.I.E.N.A.®, which fuses human clinical expertise with AI and Machine Learning technology resulting in evidence-based, unbiased patient/physician-matching outcomes.
To learn more about the Opportunity Analysis and the new partnership, please contact David Lauritzen of Healthcare Strategies at 800-582-1535, ext. 3209.
About Healthcare Strategies
HealthCare Strategies (HCS) applies over 38 years of experience providing health management and member advocacy through technology and population health management, reducing cost and improving the health of the population. Our HealthReach Predictive Care Management® program combines actionable analytics with interactive RN intervention. HealthReach is a unique alternative to disease management that identifies all future and emerging risk within population regardless of disease and cost. HCS provides effective care management, case management and utilization services executed by registered nurses nationwide. Visit us at www.hcare.net.
ArmadaHealth® has developed the most robust and comprehensive physician-recommendation intelligence in the industry. Uniting oceans of data, clinical insights and a human touch, our High Tech, Right Touch® approach embodies the best practices in quality-based clinical navigation. Our proprietary enhanced intelligence platform, S.I.E.N.A.®, features multivariate quality measures and clinically trained machine-learning models as inputs to physician-patient matching algorithms. QualityCare Connect®, our flagship consumer-facing service, improves the efficiency, expediency and effectiveness of how people access perfectly matched primary and specialty-care physicians. QualityCare Navigator™, our Navigation-as-a-Service offering, enables our clients’ member-facing service teams to submit, monitor and manage navigations on behalf of their members with a private-labeled solution. The result is improved health outcomes, reduced healthcare expenses and exceptional member satisfaction as reflected in our NPS of 86 while serving more than two million members. ArmadaHealth is a portfolio company of Sirius Group. Learn more at www.ArmadaHealth.com.
Cautionary Note Regarding Forward-Looking Statements
We have made statements in this press release that are forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, including statements about the success of the strategic review and/or sale of the Company. You can identify forward-looking statements by the use of forward-looking terminology such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “target,” “continue,” “could,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “should,” “would,” “seeks,” “likely,” and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the management and speak only as of the date of this document. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.